189 related articles for article (PubMed ID: 10215702)
1. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
Yabe Y; Nishikawa M; Tamada A; Takakura Y; Hashida M
J Pharmacol Exp Ther; 1999 May; 289(2):1176-84. PubMed ID: 10215702
[TBL] [Abstract][Full Text] [Related]
2. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives.
Yabe Y; Kobayashi N; Nishihashi T; Takahashi R; Nishikawa M; Takakura Y; Hashida M
J Pharmacol Exp Ther; 2001 Sep; 298(3):894-9. PubMed ID: 11504782
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation.
Mizoe A; Kondo S; Azuma T; Fujioka H; Tanaka K; Hashida M; Kanematsu T
J Surg Res; 1997 Dec; 73(2):160-5. PubMed ID: 9441811
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of safe and novel SOD derivatives, galactosylated-SOD, on hepatic warm ischemia/reperfusion injury in pigs.
Yuzawa H; Fujioka H; Mizoe A; Azuma T; Furui J; Nishikawa M; Hashida M; Kanematsu T
Hepatogastroenterology; 2005; 52(63):839-43. PubMed ID: 15966216
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific distribution of catalase and its inhibitory effect on hepatic ischemia/reperfusion injury in mice.
Yabe Y; Koyama Y; Nishikawa M; Takakura Y; Hashida M
Free Radic Res; 1999 Apr; 30(4):265-74. PubMed ID: 10230805
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of the complex between manganese porphyrins and catalase-poly(ethylene glycol) conjugates against hepatic ischemia/reperfusion injury in vivo.
Hanawa T; Asayama S; Watanabe T; Owada S; Kawakami H
J Control Release; 2009 Apr; 135(1):60-4. PubMed ID: 19162102
[TBL] [Abstract][Full Text] [Related]
7. Mannosylated superoxide dismutase inhibits hepatic reperfusion injury in rats.
Kondo S; Segawa T; Tanaka K; Izawa K; Hashida M; Kanematsu T
J Surg Res; 1996 Jan; 60(1):36-40. PubMed ID: 8592429
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hepatic ischemia/reperfusion injury by prolonged delivery of nitric oxide to the circulating blood in mice.
Katsumi H; Nishikawa M; Yamashita F; Hashida M
Transplantation; 2008 Jan; 85(2):264-9. PubMed ID: 18212632
[TBL] [Abstract][Full Text] [Related]
9. Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice.
Katsumi H; Nishikawa M; Yasui H; Yamashita F; Hashida M
J Control Release; 2009 Nov; 140(1):12-7. PubMed ID: 19646492
[TBL] [Abstract][Full Text] [Related]
10. Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion.
Zhou W; Zhang Y; Hosch MS; Lang A; Zwacka RM; Engelhardt JF
Hepatology; 2001 Apr; 33(4):902-14. PubMed ID: 11283855
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.
Fujita T; Nishikawa M; Tamaki C; Takakura Y; Hashida M; Sezaki H
J Pharmacol Exp Ther; 1992 Dec; 263(3):971-8. PubMed ID: 1469654
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and preventive effects of targeted catalase derivatives on hydrogen peroxide-induced injury in perfused rat liver.
Yabe Y; Kobayashi N; Nishikawa M; Mihara K; Yamashita F; Takakura Y; Hashida M
Pharm Res; 2002 Dec; 19(12):1815-21. PubMed ID: 12523659
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectors.
Ushitora M; Sakurai F; Yamaguchi T; Nakamura S; Kondoh M; Yagi K; Kawabata K; Mizuguchi H
J Control Release; 2010 Mar; 142(3):431-7. PubMed ID: 19951728
[TBL] [Abstract][Full Text] [Related]
14. Improved anti-oxidant activity of superoxide dismutase by direct chemical modification.
Ishimoto N; Nemoto T; Nagayoshi K; Yamashita F; Hashida M
J Control Release; 2006 Mar; 111(1-2):204-11. PubMed ID: 16466666
[TBL] [Abstract][Full Text] [Related]
15. Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol.
Mihara K; Oka Y; Sawai K; Takakura Y; Hashida M
J Drug Target; 1994; 2(4):317-21. PubMed ID: 7858957
[TBL] [Abstract][Full Text] [Related]
16. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice.
Contreras JL; Vilatoba M; Eckstein C; Bilbao G; Anthony Thompson J; Eckhoff DE
Surgery; 2004 Aug; 136(2):390-400. PubMed ID: 15300206
[TBL] [Abstract][Full Text] [Related]
17. The protective effects of 17beta-estradiol on hepatic ischemia-reperfusion injury in rat model, associated with regulation of heat-shock protein expression.
Shen SQ; Zhang Y; Xiong CL
J Surg Res; 2007 Jun; 140(1):67-76. PubMed ID: 17336333
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic Delivery of Pegylated Catalase Is Protective in a Rat Ischemia/Reperfusion Injury Model.
Akateh C; Beal EW; Kim JL; Reader BF; Maynard K; Zweier JL; Whitson BA; Black SM
J Surg Res; 2019 Jun; 238():152-163. PubMed ID: 30771685
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
Ogawara K; Hasegawa S; Nishikawa M; Takakura Y; Hashida M
J Drug Target; 1999; 6(5):349-60. PubMed ID: 10342383
[TBL] [Abstract][Full Text] [Related]
20. Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver.
Nag A; Ghosh PC
J Drug Target; 1999; 6(6):427-38. PubMed ID: 10937288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
